Patel T, Bander ED, Venn RA, Powell T, Cederquist GYoung-Min, Schaefer PM, Puchi LA, Akhmerov A, Ogilvie S, Reiner AS et al..  2018.  The Role of Extent of Resection in IDH1 Wild-Type or Mutant Low-Grade Gliomas.. Neurosurgery. 82(6):808-814.

Ptashkin RN, Pagan C, Yaeger R, Middha S, Shia J, O'Rourke KP, Berger MF, Wang L, Cimera R, Wang J et al..  2017.  Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-Sided Colon Cancers with Wild-type RAS/RAF and Better Overall Survival.. Mol Cancer Res. 15(6):708-713.

Lockney NA, Wang DG, Gutin PH, Brennan C, Tabar V, Ballangrud A, Pei X, Chan TA, Yamada Y, T Yang J et al..  2017.  Clinical outcomes of patients with limited brain metastases treated with hypofractionated (5×6Gy) conformal radiotherapy.. Radiother Oncol. 123(2):203-208.

Morton LM, Sampson JN, Armstrong GT, Chen T-H, Hudson MM, Karlins E, Dagnall CL, Li SAlfred, Wilson CL, Srivastava DKumar et al..  2017.  Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.. J Natl Cancer Inst. 109(11)

Hosono N, Makishima H, Mahfouz R, Przychodzen B, Yoshida K, Jerez A, LaFramboise T, Polprasert C, Clemente MJ, Shiraishi Y et al..  2017.  Recurrent genetic defects on chromosome 5q in myeloid neoplasms.. Oncotarget. 8(4):6483-6495.

Armstrong EJ, Sab S, Singh GD, Lim W, Yeo K-K, Waldo SW, Patel M, Reeves R, MacGregor JS, Low RI et al..  2014.  Predictors and outcomes of recurrent stent thrombosis: results from a multicenter registry.. JACC Cardiovasc Interv. 7(10):1105-13.

Brunner AM, Campigotto F, Sadrzadeh H, Drapkin BJ, Bin Chen Y-, Neuberg DS, Fathi AT.  2013.  Trends in all-cause mortality among patients with chronic myeloid leukemia: a Surveillance, Epidemiology, and End Results database analysis.. Cancer. 119(14):2620-9.